1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Intravenous Immunoglobulins Revenue
1.4 Market Analysis by Type
1.4.1 Global Intravenous Immunoglobulins Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Neurology Intravenous Immunoglobulins
1.4.3 Hematology Intravenous Immunoglobulins
1.4.4 Immunology Intravenous Immunoglobulins
1.5 Market by Application
1.5.1 Global Intravenous Immunoglobulins Market Share by Application: 2021-2026
1.5.2 Primary Immunodeficiency
1.5.3 Idiopathic Thrombocytopenic Purpura
1.5.4 Chronic Inflammatory Demyelinating Polyneuropathy
1.5.5 Kawasaki Disease
1.5.6 Guillain-Barre Syndrome
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Intravenous Immunoglobulins Market
1.8.1 Global Intravenous Immunoglobulins Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Intravenous Immunoglobulins Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Intravenous Immunoglobulins Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Intravenous Immunoglobulins Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Intravenous Immunoglobulins Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Intravenous Immunoglobulins Sales Volume Market Share by Region (2015-2020)
3.2 Global Intravenous Immunoglobulins Sales Revenue Market Share by Region (2015-2020)
3.3 North America Intravenous Immunoglobulins Sales Volume
3.3.1 North America Intravenous Immunoglobulins Sales Volume Growth Rate (2015-2020)
3.3.2 North America Intravenous Immunoglobulins Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Intravenous Immunoglobulins Sales Volume
3.4.1 East Asia Intravenous Immunoglobulins Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Intravenous Immunoglobulins Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Intravenous Immunoglobulins Sales Volume (2015-2020)
3.5.1 Europe Intravenous Immunoglobulins Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Intravenous Immunoglobulins Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Intravenous Immunoglobulins Sales Volume (2015-2020)
3.6.1 South Asia Intravenous Immunoglobulins Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Intravenous Immunoglobulins Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Intravenous Immunoglobulins Sales Volume (2015-2020)
3.7.1 Southeast Asia Intravenous Immunoglobulins Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Intravenous Immunoglobulins Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Intravenous Immunoglobulins Sales Volume (2015-2020)
3.8.1 Middle East Intravenous Immunoglobulins Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Intravenous Immunoglobulins Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Intravenous Immunoglobulins Sales Volume (2015-2020)
3.9.1 Africa Intravenous Immunoglobulins Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Intravenous Immunoglobulins Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Intravenous Immunoglobulins Sales Volume (2015-2020)
3.10.1 Oceania Intravenous Immunoglobulins Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Intravenous Immunoglobulins Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Intravenous Immunoglobulins Sales Volume (2015-2020)
3.11.1 South America Intravenous Immunoglobulins Sales Volume Growth Rate (2015-2020)
3.11.2 South America Intravenous Immunoglobulins Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Intravenous Immunoglobulins Sales Volume (2015-2020)
3.12.1 Rest of the World Intravenous Immunoglobulins Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Intravenous Immunoglobulins Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Intravenous Immunoglobulins Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Intravenous Immunoglobulins Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Intravenous Immunoglobulins Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Intravenous Immunoglobulins Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Intravenous Immunoglobulins Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Intravenous Immunoglobulins Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Intravenous Immunoglobulins Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Intravenous Immunoglobulins Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Intravenous Immunoglobulins Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Intravenous Immunoglobulins Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Intravenous Immunoglobulins Sales Volume Market Share by Type (2015-2020)
14.2 Global Intravenous Immunoglobulins Sales Revenue Market Share by Type (2015-2020)
14.3 Global Intravenous Immunoglobulins Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Intravenous Immunoglobulins Consumption Volume by Application (2015-2020)
15.2 Global Intravenous Immunoglobulins Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Intravenous Immunoglobulins Business
16.1 CSL Behring
16.1.1 CSL Behring Company Profile
16.1.2 CSL Behring Intravenous Immunoglobulins Product Specification
16.1.3 CSL Behring Intravenous Immunoglobulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Biotest
16.2.1 Biotest Company Profile
16.2.2 Biotest Intravenous Immunoglobulins Product Specification
16.2.3 Biotest Intravenous Immunoglobulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Takeda
16.3.1 Takeda Company Profile
16.3.2 Takeda Intravenous Immunoglobulins Product Specification
16.3.3 Takeda Intravenous Immunoglobulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Grifols
16.4.1 Grifols Company Profile
16.4.2 Grifols Intravenous Immunoglobulins Product Specification
16.4.3 Grifols Intravenous Immunoglobulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Bharat Serum and Vaccines
16.5.1 Bharat Serum and Vaccines Company Profile
16.5.2 Bharat Serum and Vaccines Intravenous Immunoglobulins Product Specification
16.5.3 Bharat Serum and Vaccines Intravenous Immunoglobulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Octapharma
16.6.1 Octapharma Company Profile
16.6.2 Octapharma Intravenous Immunoglobulins Product Specification
16.6.3 Octapharma Intravenous Immunoglobulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Hualan Biological Engineering
16.7.1 Hualan Biological Engineering Company Profile
16.7.2 Hualan Biological Engineering Intravenous Immunoglobulins Product Specification
16.7.3 Hualan Biological Engineering Intravenous Immunoglobulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Bayer
16.8.1 Bayer Company Profile
16.8.2 Bayer Intravenous Immunoglobulins Product Specification
16.8.3 Bayer Intravenous Immunoglobulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 ADMA Biologics
16.9.1 ADMA Biologics Company Profile
16.9.2 ADMA Biologics Intravenous Immunoglobulins Product Specification
16.9.3 ADMA Biologics Intravenous Immunoglobulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 China Biologic Products
16.10.1 China Biologic Products Company Profile
16.10.2 China Biologic Products Intravenous Immunoglobulins Product Specification
16.10.3 China Biologic Products Intravenous Immunoglobulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Kedrion Biopharma
16.11.1 Kedrion Biopharma Company Profile
16.11.2 Kedrion Biopharma Intravenous Immunoglobulins Product Specification
16.11.3 Kedrion Biopharma Intravenous Immunoglobulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 LFB Group
16.12.1 LFB Group Company Profile
16.12.2 LFB Group Intravenous Immunoglobulins Product Specification
16.12.3 LFB Group Intravenous Immunoglobulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 Sanquin
16.13.1 Sanquin Company Profile
16.13.2 Sanquin Intravenous Immunoglobulins Product Specification
16.13.3 Sanquin Intravenous Immunoglobulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Intravenous Immunoglobulins Manufacturing Cost Analysis
17.1 Intravenous Immunoglobulins Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Intravenous Immunoglobulins
17.4 Intravenous Immunoglobulins Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Intravenous Immunoglobulins Distributors List
18.3 Intravenous Immunoglobulins Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Intravenous Immunoglobulins (2021-2026)
20.2 Global Forecasted Revenue of Intravenous Immunoglobulins (2021-2026)
20.3 Global Forecasted Price of Intravenous Immunoglobulins (2015-2026)
20.4 Global Forecasted Production of Intravenous Immunoglobulins by Region (2021-2026)
20.4.1 North America Intravenous Immunoglobulins Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Intravenous Immunoglobulins Production, Revenue Forecast (2021-2026)
20.4.3 Europe Intravenous Immunoglobulins Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Intravenous Immunoglobulins Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Intravenous Immunoglobulins Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Intravenous Immunoglobulins Production, Revenue Forecast (2021-2026)
20.4.7 Africa Intravenous Immunoglobulins Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Intravenous Immunoglobulins Production, Revenue Forecast (2021-2026)
20.4.9 South America Intravenous Immunoglobulins Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Intravenous Immunoglobulins Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Intravenous Immunoglobulins by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Intravenous Immunoglobulins by Country
21.2 East Asia Market Forecasted Consumption of Intravenous Immunoglobulins by Country
21.3 Europe Market Forecasted Consumption of Intravenous Immunoglobulins by Countriy
21.4 South Asia Forecasted Consumption of Intravenous Immunoglobulins by Country
21.5 Southeast Asia Forecasted Consumption of Intravenous Immunoglobulins by Country
21.6 Middle East Forecasted Consumption of Intravenous Immunoglobulins by Country
21.7 Africa Forecasted Consumption of Intravenous Immunoglobulins by Country
21.8 Oceania Forecasted Consumption of Intravenous Immunoglobulins by Country
21.9 South America Forecasted Consumption of Intravenous Immunoglobulins by Country
21.10 Rest of the world Forecasted Consumption of Intravenous Immunoglobulins by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer